Arguably the most interesting finding of our main GWAS analyses is the discovery of genome-wide significant gene-based association with variants in GRIN2D on chromosome 19q13.33 and the non-AD synaptic functioning component (PC5), mainly driven by Ng levels. This evidence concerns the gene GRIN2D and Alzheimer disease.